QP905 .H236s v. 175eb
|
Neurotransmitter transporters |
1 |
QP905 .H3
|
Handbuch der experimentellen Pharmakologie. |
1 |
QP905 .H3 2005
|
Cannabinoids / |
1 |
QP905 .H3 Bd. 34
|
Secretin, cholecystokinin, pancreozymin and gastrin |
1 |
QP905 .H3 Bd. 36
|
Uranium, plutonium, transplutonic elements |
1 |
QP905 .H3eb vol. 180
|
Bone marrow-derived progenitors |
1 |
QP905.H3 V176 PT. 2 2006eb
|
The vascular endothelium. |
1 |
QP905 .H3 vol. 50/1
|
Inflammation / |
1 |
QP905 .H3 vol. 50/1 RB131
|
Inflammation / |
1 |
QP905 .H3 vol. 50/2
|
Anti-inflammatory drugs / |
1 |
QP905 .H3 vol. 50/2 RM405
|
Anti-inflammatory drugs / |
1 |
QP905 .H3 vol. 51
|
Uric acid / |
1 |
QP905 .H3 vol. 51 RC629
|
Uric acid / |
1 |
QP905 .H3 vol. 52
|
Snake venoms / |
1 |
QP905 .H3 vol. 53
|
Pharmacology of ganglionic transmission / |
1 |
QP905 .H3 vol. 53 RM323
|
Pharmacology of ganglionic transmission / |
1 |
QP905 .H3 vol. 54
|
Adrenergic activators and inhibitors / |
1 |
QP905 .H3 vol. 54 RM323.6
|
Adrenergic activators and inhibitors / |
1 |
QP905 .H3 vol. 55
|
Psychotropic agents / |
1 |
QP905 .H3 vol. 55/I, RM333
|
Antipsychotics and antidepressants / |
1 |